Status:
COMPLETED
A Randomized Cross-over Study for Normal Pressure Hydrocephalus
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
Aesculap, Inc.
Ohio State University
Conditions:
Normal Pressure Hydrocephalus
Eligibility:
All Genders
60-85 years
Phase:
NA
Brief Summary
The goal of our study is to verify the effectiveness of the shunt and to identify the most sensitive criteria to select patients for surgery. The study is designed to assess improvement in walking and...
Detailed Description
Normal Pressure Hydrocephalus (NPH) causes memory loss, walking, and urinary difficulties. If NPH goes unidentified and untreated it can cause severe disability. The cause of this disease is poorly un...
Eligibility Criteria
Inclusion
- Age of Patients ( between 60 to 85 years old)
- Clinically suspected Normal Pressure Hydrocephalus (NPH) with at least gait impairment
- Informed consent from patient
Exclusion
- Etiology for hydrocephalus other than idiopathic normal pressure hydrocephalus
- Patients not capable of providing an informed consent.
- History of intra-cerebral hemorrhage
- Cardiac Pacemaker
Key Trial Info
Start Date :
January 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 14 2017
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT01798641
Start Date
January 1 2013
End Date
September 14 2017
Last Update
November 2 2018
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins University
Baltimore, Maryland, United States, 21284
2
Henry Ford Health System
Detroit, Michigan, United States, 48202
3
Ohio State University
Columbus, Ohio, United States, 43210
4
Rhode Island Hospital
Providence, Rhode Island, United States, 02903